Page last updated: 2024-10-30

mesalamine and Anti-Glomerular Basement Membrane Disease

mesalamine has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Anti-Glomerular Basement Membrane Disease: An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koçak, E1
Köklü, S1
Akbal, E1
Huddam, B1
Azak, A1
Yilmaz, SR1

Other Studies

1 other study available for mesalamine and Anti-Glomerular Basement Membrane Disease

ArticleYear
Development of glomerulonephritis early in the course of Crohn's disease.
    Inflammatory bowel diseases, 2010, Volume: 16, Issue:4

    Topics: Adult; Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents, Non-Steroidal; Autoantib

2010